Top of this page
Skip navigation, go straight to the content

Our Company Management
 

Executive Committee

 

Jean-Christophe Tellier

Jean-Christophe Tellier

Chief Executive Officer &
Chairman of the Executive Committee

Joined UCB in June 2011
Appointed as CEO in January 2015

Emmanuel Caeymaex

Emmanuel Caeymaex

Executive Vice President
Immunology Solutions & Head of US

Joined UCB in March 1994
Appointed in February 2015

Jean-Luc Fleurial

Jean-Luc Fleurial

Executive Vice President &
Chief Human Resources Officer

Joined UCB in September 2017
Appointed in September 2017

Iris Loew-Friedrich

Iris Loew-Friedrich

Executive Vice President &
Chief Medical Officer

Joined UCB in September 2006
Appointed in March 2008

Kirsten Lund-Jurgensen

Kirsten Lund-Jurgensen

Executive Vice President,
Supply & Technology Solutions

Joined UCB in 2019
Appointed in September 2019

Dhavalkumar Patel

Dhavalkumar Patel

Executive Vice President &
Chief Scientific Officer

Joined UCB in October 2017
Appointed in October 2017

Bill Silbey

Bill Silbey

Executive Vice-President &
General Counsel

Joined UCB in 2011
Appointed in March 2019

Charl van Zyl

Charl van Zyl

Executive Vice President Neurology Solutions & Head of EU/International

Joined UCB in March 2017
Appointed in March 2017

CFO transition


Detlef Thielgen stepped down from the Executive Committee as of 10 April 2020.

Sandrine Dufour will join UCB and take over the CFO position as of 1 July 2020.

Jean-Christophe Tellier will ensure the interim role of CFO in the meantime.